Bioworld Financial Watch articles from April 2005

Bioworld Financial Watch archives from April 2005

Pipeline drugs lining up to compete in major PAH market.
April 4, 2005... A spate of news at the start of this year regarding therapies for pulmonary arterial hypertension (PAH) threw fresh light on the disorder--and might put eventual pressure on the Swiss firm Actelion Ltd., which markets the only approved oral...

10 biggest U.S. gainers for the week.
April 4, 2005... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) Northwest BioThera 27.78 Peregrine Pharma 19.08 Questcor Pharma 17.65 New River 12.47 Introgen 11.58 DOR BioPharma 11.11 Accelrys Inc...

10 biggest U.S. losers for the week.
April 4, 2005... 10 BIGGEST U.S. LOSERS FOR THE WEEK (By Percent) Corgentech -54.37 Ligand -30.98 Cellegy Pharma -26.83 Xcyte Therapies -25.17 Praecis -24.41 NeoRx Corp. -24.00 Novavax -23.98...

Biotech mergers and acquisitions: Jan. 1-April 1, 2005 (#).
April 4, 2005... Biotech Mergers And Acquisitions: Jan. 1-April 1, 2005 (#) I. COMPLETED MERGERS AND ACQUISITIONS Company Acquired By Date Acquired * Or Merged With * Announced (Country; Symbol) (Country;...

BioWorld stock report for public biotechnology companies.
April 4, 2005... BioWorld Stock Report For Public Biotechnology Companies % Change Company Symbol Close Close Vol 3/24 4/1 ...

Casualty-strewn melanoma race: CancerVax falters, but stays in.
April 11, 2005... Shortly before Christmas last year, when Serono SA signed a potential $290 million deal with CancerVax Corp., the drug at the center of the agreement--lead product Canvaxin, a Phase III compound targeting advanced melanoma--seemed like a gift...

10 biggest U.S. gainers for the week.
April 11, 2005... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) (By Dollars) Generex Biotech 43.40 Gen-Probe 6.10 EntreMed 38.22 OSI Pharma 4.48 Kosan 28.64 Invitrogen 3.69 Threshold...

10 biggest U.S. losers for the week.
April 11, 2005... 10 BIGGEST U.S. LOSERS FOR THE WEEK (By Percent) (By Dollars) CancerVax -54.43 CancerVax -3.44 Immune Resp -34.15 Solexa -1.62 Ciphergen -27.86 Neurochem ...

Public financing of biotechnology: March 2005.
April 11, 2005... Public Financing Of Biotechnology: March 2005 I. COMMENCED TRADING IN MARCH Company Date Date Shares/ (Symbol) (#) Filed Comm. Units (M) INITIAL OFFERINGS Ardana plc ...

Other financings of public biotechnology companies: March 2005.
April 11, 2005... Other Financings Of Public Biotechnology Companies: March 2005 TOTAL: $717.04M Number Of Shares, Units Amount Company Type Of Or...

Venture capital and corporate investments in biotechnology companies: March 2005.
April 11, 2005... Venture Capital And Corporate Investments In Biotechnology Companies: March 2005 I. FINANCING OF PRIVATE BIOTECHNOLOGY COMPANIES: $276.4M Company Location Date Amt. (M) Agennix Inc. Houston ...

Money raised by biotech in 2005: January-March.
April 11, 2005... Money Raised By Biotech In 2005: January-March Type of financing Jan. Feb. Mar. Total ($M) Public offerings 585.7 799.4 303.9 1,688.96 Private biotechs 406.3 636.6 276.4 1,319.25...

BioWorld stock report for public biotechnology companies.
April 11, 2005... BioWorld Stock Report For Public Biotechnology Companies Close Close Company Symbol 4/1 4/8 Aastrom Biosci ASTM 2.11 2.16 Abgenix ABGX 6.86...

Fosrenol's threat to Renagel may be leveling off: report.(More Lanthanum Drugs In The Works)
April 18, 2005... Earlier this month, powerhouse Genzyme Corp. disclosed its launch of Phase III trials with the toxin binder tolevamer for patients with Clostridium difficile-associated diarrhea--a compound that derives from the same platform that yielded...

10 biggest U.S. gainers for the week.
April 18, 2005... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) Targeted Genetics 50.75 Transgenomic 35.94 Genentech 20.27 Insmed 20.00 Northfield Labs 18.80 Cellegy Pharma 18.57 Icoria ...

10 biggest U.S. losers for the week.
April 18, 2005... 10 BIGGEST U.S. LOSERS FOR THE WEEK (By Percent) Memory -38.18 Cardiovascular Bio -21.95 Stratagene -20.02 Miravant -20.00 Simulations Plus -17.59 GTC Biothera ...

Clinical trials update: March 2005.
April 18, 2005... Clinical Trials Update: March 2005 Company * Product Description (Country; Symbol) AUTOIMMUNE Astralis Ltd. Psoraxine Protein-based (OTC BB:ASTR) immunostimulator ...

Non-U.S. clinical trials, regulatory submissions, recommendations and approvals: March 2005.
April 18, 2005... Non-U.S. Clinical Trials, Regulatory Submissions, Recommendations And Approvals: March 2005 Company * Product Description (Country; Symbol) AUTOIMMUNE 4SC AG * SC12267 Small molecule...

FDA submissions, approvals and other actions: March 2005.
April 18, 2005... FDA Submissions, Approvals And Other Actions: March 2005 Company * Product Description (Country; Symbol) AUTOIMMUNE La Jolla Riquent Abetimus sodium; B-cell Pharmaceutical ...

BioWorld stock report for public biotechnology companies.
April 18, 2005... BioWorld Stock Report For Public Biotechnology Companies % Change Company Symbol Close Close Vol 4/8 4/15 ...

With Shire's $1.6b buyout, TKT on 'verge of becoming great'.
April 25, 2005... It seemed bound to happen. Getting ready to sign a partner in Europe for Dynepo (epoetin delta), its version of erythropoietin, Transkaryotic Therapies Inc. had been bracing an eager market for data from the pivotal Phase III trial with...

10 biggest U.S. gainers for the week.
April 25, 2005... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) Access Pharma 50.00 Critical Thera 28.46 Genta 27.78 Immune Resp 20.00 Dyax 17.65 Ortec Int'l 17.14 Kosan 16.23...

10 biggest U.S. losers for the week.
April 25, 2005... 10 BIGGEST U.S. LOSERS FOR THE WEEK (By Percent) Neurochem -31.71 Targeted Genetics -25.74 La Jolla Pharma -20.00 Osteotech -17.90 Ista Pharma -15.56 Memory -15.44 Cytokinetics...

Biotechnology company deals with other biotechnology companies: collaborations and other agreements, Feb. 17-April 20, 2005.
April 25, 2005... Biotechnology Company Deals With Other Biotechnology Companies: Collaborations And Other Agreements, Feb. 17-April 20, 2005 Company * Company * Type/Product Area (Country; (Country; Symbol) ...

Biotechnology company deals with miscellaneous companies: collaborations, agreements, equity participation, Feb. 17-April 20, 2005.
April 25, 2005... Biotechnology Company Deals With Miscellaneous Companies: Collaborations, Agreements, Equity Participation, Feb. 17-April 20, 2005 Company * Company Type/Product Area (Country; Symbol) Diversa Corp. ...

Manufacturing, marketing and distribution agreements between biotech companies: Feb. 17-April 20, 2005.
April 25, 2005... Manufacturing, Marketing And Distribution Agreements Between Biotech Companies: Feb. 17-April 20, 2005 Company * Company * Product (Country; (Country; Symbol) Symbol) Agencourt Amplicon...

Biotech--biotech collaborations: modified and terminated agreements, Feb. 17-April 20, 2005.
April 25, 2005... Biotech--Biotech Collaborations: Modified And Terminated Agreements, Feb. 17-April 20, 2005 I. MODIFIED AGREEMENTS Company * Company * Change from original (Country; (Country; agreement Symbol) ...

BioWorld stock report for public biotechnology companies.
April 25, 2005... BioWorld Stock Report For Public Biotechnology Companies % Change Company Symbol Close Close Vol 4/15 4/22 ...